FDA Inspection
Catalent Belgium SACatalent Belgium SA – FDA Inspection, Jan 22, 2020
Record Details
This FDA Inspection record concerns Catalent Belgium SA, with an inspection on January 22, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Catalent Belgium SA
- Inspection Date
- January 22, 2020
- Product Type
- Drugs
View Company Profile
ID · 718d5f13-8833-4845-b87e-2fd3dce9c475
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1136201
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Catalent Belgium SA
13| Date | Classification | Office | Project area |
|---|---|---|---|
| July 12, 2024 | Not classified | Office of Inspections and Investigations | |
| April 7, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 15, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Catalent Belgium SA
- FDA Inspection 1273463 - 2024-07-12
- FDA Inspection 1246550 - 2023-04-07
- FDA Inspection 1177876 - 2022-08-19
- FDA Inspection 1093395 - 2019-06-19
- FDA Inspection 1082390 - 2019-02-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.